{"id":"https://openalex.org/W4411038940","doi":"https://doi.org/10.1158/1535-7163.c.7856561","title":"Data from 177Lu-Labeled Antibody\u2013Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors","display_name":"Data from 177Lu-Labeled Antibody\u2013Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors","publication_year":2025,"publication_date":"2025-06-04","ids":{"openalex":"https://openalex.org/W4411038940","doi":"https://doi.org/10.1158/1535-7163.c.7856561"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.7856561","doi":"https://doi.org/10.1158/1535-7163.c.7856561","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.7856561","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.7856561","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087626746","display_name":"Aiko Yamaguchi","orcid":"https://orcid.org/0000-0002-7631-3164","observed_orcids":["https://orcid.org/0000-0002-7631-3164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aiko Yamaguchi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7631-3164","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063974451","display_name":"Chisato M. Yamazaki","orcid":"https://orcid.org/0000-0002-0785-7352","observed_orcids":["https://orcid.org/0000-0002-0785-7352"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chisato M. Yamazaki","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0785-7352","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069745826","display_name":"Yasuaki Anami","orcid":"https://orcid.org/0000-0001-5136-7708","observed_orcids":["https://orcid.org/0000-0001-5136-7708"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasuaki Anami","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5136-7708","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003763671","display_name":"Summer Y.Y. Ha","orcid":"https://orcid.org/0000-0002-5297-3686","observed_orcids":["https://orcid.org/0000-0002-5297-3686"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Summer Y.Y. Ha","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5297-3686","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036408326","display_name":"Wei Xiong","orcid":"https://orcid.org/0000-0003-2624-6474","observed_orcids":["https://orcid.org/0000-0003-2624-6474"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Xiong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2624-6474","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049842114","display_name":"Robert T. Ta","orcid":"https://orcid.org/0000-0001-8075-9639","observed_orcids":["https://orcid.org/0000-0001-8075-9639"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert T. Ta","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8075-9639","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100320378","display_name":"Ningyan Zhang","orcid":"https://orcid.org/0000-0002-4348-2180","observed_orcids":["https://orcid.org/0000-0002-4348-2180"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ningyan Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4348-2180","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062023116","display_name":"H. Charles Manning","orcid":"https://orcid.org/0000-0002-2042-8800","observed_orcids":["https://orcid.org/0000-0002-2042-8800"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Charles Manning","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2042-8800","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026356376","display_name":"Zhiqiang An","orcid":"https://orcid.org/0000-0001-9309-2335","observed_orcids":["https://orcid.org/0000-0001-9309-2335","https://orcid.org/0000-0002-4348-2180"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhiqiang An","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9309-2335","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5022743912","display_name":"Kyoji Tsuchikama","orcid":"https://orcid.org/0000-0002-2359-0408","observed_orcids":["https://orcid.org/0000-0002-2359-0408"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kyoji Tsuchikama","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2359-0408","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lutetium-177","display_name":"lutetium-177","score":0.906000018119812},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9850000143051147},{"id":"https://openalex.org/keywords/trop2","display_name":"TROP2","score":0.8740000128746033},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.9810000061988831},{"id":"https://openalex.org/keywords/dtpa-chelator","display_name":"DTPA chelator","score":0.8040000200271606},{"id":"https://openalex.org/keywords/do3a","display_name":"DO3A","score":0.7580000162124634},{"id":"https://openalex.org/keywords/monomethyl-auristatin-e","display_name":"monomethyl auristatin E","score":0.9340000152587891},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6539999842643738},{"id":"https://openalex.org/keywords/refractory-cancer","display_name":"refractory cancer","score":0.7900000214576721},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.6019999980926514},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5799999833106995}],"concepts":[{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.8211312294006348},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.7777700424194336},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5464337468147278},{"id":"https://openalex.org/C2780226545","wikidata":"https://www.wikidata.org/wiki/Q6888030","display_name":"Modality (human\u2013computer interaction)","level":2,"score":0.47498196363449097},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46702030301094055},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46233245730400085},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.44266897439956665},{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.4408876895904541},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3337025046348572},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31746697425842285},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.23082447052001953},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.22821277379989624},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.206567645072937},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17279702425003052},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.1468372642993927},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13587820529937744},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.09895023703575134},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.0},{"id":"https://openalex.org/C124952713","wikidata":"https://www.wikidata.org/wiki/Q8242","display_name":"Literature","level":1,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.7856561","doi":"https://doi.org/10.1158/1535-7163.c.7856561","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.7856561","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.7856561","doi":"https://doi.org/10.1158/1535-7163.c.7856561","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.7856561","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4408239099","https://openalex.org/W4416086910","https://openalex.org/W7095489862","https://openalex.org/W3163390014","https://openalex.org/W4410918130","https://openalex.org/W4414163422","https://openalex.org/W2101638553","https://openalex.org/W7214960548","https://openalex.org/W2103466020","https://openalex.org/W4362541424"],"abstract_inverted_index":{"Abstract":[0],"To":[1],"explore":[2],"the":[3,63,94,97,111,122,139,179],"potential":[4],"of":[5,181],"site-selectively":[6,213],"radiolabeled":[7,18],"antibody\u2013drug":[8],"conjugates":[9],"(ADC)":[10],"against":[11],"solid":[12,240],"tumors,":[13,221],"we":[14,76],"constructed":[15],"and":[16,24,49,62,71,80,101,178,189,196,228],"evaluated":[17],"ADCs":[19,31,38,61,215],"equipped":[20],"with":[21,68,93,224],"lutetium-177":[22],"(177Lu)":[23],"a":[25,43,200,233],"membrane-permeable":[26],"antimitotic":[27],"agent.":[28],"Site-selective":[29],"177Lu-labeled":[30,44,50,60,214],"[anti\u2013trophoblast":[32],"cell-surface":[33],"antigen":[34,226],"2":[35,166,186],"(TROP2)":[36],"177Lu-DTPA":[37,98,125],"or":[39],"anti-HER2":[40,172,190],"177Lu-DO3A":[41,149],"ADCs],":[42],"homogeneous":[45,64,103,141,173,191],"radioimmunoconjugate":[46],"(homogeneous":[47],"RIC),":[48],"conventional":[51],"RIC":[52,65,104,142,174,192],"(heterogeneous":[53],"RIC)":[54],"were":[55,66],"constructed.":[56],"We":[57],"confirmed":[58],"that":[59,212],"obtained":[67],"high":[69],"homogeneity":[70],"defined":[72],"chelator/payload-to-antibody":[73],"ratios.":[74],"Next,":[75],"performed":[77],"biodistribution":[78],"studies":[79,83],"treatment":[81,159,237],"efficacy":[82,160],"in":[84,110,157,199,218],"xenograft":[85],"mouse":[86],"models":[87],"bearing":[88],"orthotopic":[89],"breast":[90,202],"tumors.":[91,241],"Compared":[92],"heterogeneous":[95,206,225],"RIC,":[96],"TROP2":[99,126],"ADC":[100,127,150,168,188],"anti-TROP2":[102,140],"showed":[105],"significantly":[106,135],"improved":[107],"radioactivity":[108,197],"accumulation":[109],"TROP2-expressing":[112],"JIMT-1":[113],"tumor":[114,133,203],"(P":[115],"<":[116],"0.01":[117],"at":[118,193],"72":[119],"hours).":[120],"In":[121],"therapeutic":[123],"study,":[124],"(5":[128,143,151,175],"MBq;":[129,152],"1.5":[130],"mg/kg)":[131,154,170],"suppressed":[132],"growth":[134],"more":[136],"than":[137],"did":[138],"MBq,":[144],"P":[145],"=":[146],"0.0068).":[147],"Anti-HER2":[148],"3.0":[153],"demonstrated":[155],"greater":[156],"vivo":[158],"over":[161],"monomethyl":[162,182],"auristatin":[163,183],"E":[164,184],"DAR":[165,185],"HER2":[167,187,207],"(3.0":[169],"monotherapy,":[171,177],"MBq)":[176],"combination":[180],"matched":[194],"payload":[195],"doses":[198],"refractory":[201,220],"model":[204],"displaying":[205],"expression.":[208],"These":[209],"results":[210],"suggest":[211],"are":[216],"effective":[217],"treating":[219],"including":[222],"those":[223],"expression,":[227],"warrant":[229],"further":[230],"exploration":[231],"as":[232],"promising":[234],"single-agent,":[235],"dual-mechanistic":[236],"modality":[238],"for":[239]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-10-10T00:00:00"}